Ginkgolic acids and Ginkgo biloba extract inhibit Escherichia coli O157:H7 and Staphylococcus aureus biofilm formation.
Int J Food Microbiol
; 174: 47-55, 2014 Mar 17.
Article
in En
| MEDLINE
| ID: mdl-24457153
ABSTRACT
Infection by enterohemorrhagic Escherichia coli O157H7 (EHEC) is a worldwide problem, and there is no effective therapy. Biofilm formation is closely related to EHEC infection and is also a mechanism of antimicrobial resistance. Antibiofilm screening of 560 purified phytochemicals against EHEC showed that ginkgolic acids C151 and C171 at 5µg/ml and Ginkgo biloba extract at 100µg/ml significantly inhibited EHEC biofilm formation on the surfaces of polystyrene and glass, and on nylon membranes. Importantly, at their working concentrations, ginkgolic acids and G. biloba extract did not affect bacterial growth. Transcriptional analyses showed that ginkgolic acid C151 repressed curli genes and prophage genes in EHEC, and these findings were in-line with reduced fimbriae production and biofilm reductions. Interestingly, ginkgolic acids and G. biloba extract did not inhibit the biofilm formation of a commensal E. coli K-12 strain. In addition, ginkgolic acids and G. biloba extract inhibited the biofilm formation of three Staphylococcus aureus strains. The findings of this study suggest that plant secondary metabolites represent an important resource for biofilm inhibitors.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Staphylococcus aureus
/
Plant Extracts
/
Salicylates
/
Biofilms
/
Escherichia coli O157
/
Ginkgo biloba
/
Anti-Bacterial Agents
Language:
En
Journal:
Int J Food Microbiol
Year:
2014
Type:
Article